nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.0697	0.199	CcSEcCtD
Etomidate—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0432	0.123	CcSEcCtD
Etomidate—SLC2A1—hindbrain—amyotrophic lateral sclerosis	0.0415	0.14	CbGeAlD
Etomidate—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0409	0.117	CcSEcCtD
Etomidate—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0377	0.108	CcSEcCtD
Etomidate—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.0306	0.0874	CcSEcCtD
Etomidate—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0265	0.0754	CcSEcCtD
Etomidate—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.026	0.0741	CcSEcCtD
Etomidate—SLC2A1—embryo—amyotrophic lateral sclerosis	0.0259	0.0874	CbGeAlD
Etomidate—SLC2A1—brainstem—amyotrophic lateral sclerosis	0.0238	0.08	CbGeAlD
Etomidate—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.0162	0.0545	CbGeAlD
Etomidate—SLC2A1—spinal cord—amyotrophic lateral sclerosis	0.0148	0.0498	CbGeAlD
Etomidate—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.0143	0.0481	CbGeAlD
Etomidate—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0379	CcSEcCtD
Etomidate—SLC2A1—nervous system—amyotrophic lateral sclerosis	0.0124	0.0419	CbGeAlD
Etomidate—SLC2A1—Insulin Signaling—PTPRF—amyotrophic lateral sclerosis	0.0121	0.0344	CbGpPWpGaD
Etomidate—SLC2A1—central nervous system—amyotrophic lateral sclerosis	0.012	0.0404	CbGeAlD
Etomidate—SLC2A1—cerebellum—amyotrophic lateral sclerosis	0.0117	0.0395	CbGeAlD
Etomidate—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0332	CcSEcCtD
Etomidate—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00984	0.0281	CcSEcCtD
Etomidate—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0098	0.028	CcSEcCtD
Etomidate—SLC2A1—brain—amyotrophic lateral sclerosis	0.00952	0.0321	CbGeAlD
Etomidate—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00927	0.0312	CbGeAlD
Etomidate—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00905	0.0258	CcSEcCtD
Etomidate—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00866	0.0247	CcSEcCtD
Etomidate—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00818	0.0276	CbGeAlD
Etomidate—Pain—Riluzole—amyotrophic lateral sclerosis	0.00793	0.0226	CcSEcCtD
Etomidate—SLC2A1—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00775	0.022	CbGpPWpGaD
Etomidate—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00646	0.0218	CbGeAlD
Etomidate—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00646	0.0218	CbGeAlD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CASP12—amyotrophic lateral sclerosis	0.00644	0.0183	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—ECE1—amyotrophic lateral sclerosis	0.00644	0.0183	CbGpPWpGaD
Etomidate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00589	0.0168	CcSEcCtD
Etomidate—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00576	0.0194	CbGeAlD
Etomidate—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00576	0.0194	CbGeAlD
Etomidate—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00571	0.0192	CbGeAlD
Etomidate—GABRB2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.0057	0.0162	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00568	0.0161	CbGpPWpGaD
Etomidate—GABRG2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00522	0.0148	CbGpPWpGaD
Etomidate—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00509	0.0171	CbGeAlD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.00503	0.0143	CbGpPWpGaD
Etomidate—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00486	0.0164	CbGeAlD
Etomidate—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00486	0.0164	CbGeAlD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00472	0.0134	CbGpPWpGaD
Etomidate—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00467	0.0157	CbGeAlD
Etomidate—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00467	0.0157	CbGeAlD
Etomidate—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00457	0.0154	CbGeAlD
Etomidate—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00457	0.0154	CbGeAlD
Etomidate—GABRA1—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00456	0.0129	CbGpPWpGaD
Etomidate—SLC2A1—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.00448	0.0127	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00438	0.0124	CbGpPWpGaD
Etomidate—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00429	0.0144	CbGeAlD
Etomidate—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00413	0.0139	CbGeAlD
Etomidate—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00403	0.0136	CbGeAlD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00401	0.0114	CbGpPWpGaD
Etomidate—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.00394	0.0133	CbGeAlD
Etomidate—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.00379	0.0128	CbGeAlD
Etomidate—SLC2A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00372	0.0106	CbGpPWpGaD
Etomidate—GABRG2—brain—amyotrophic lateral sclerosis	0.00371	0.0125	CbGeAlD
Etomidate—GABRB2—brain—amyotrophic lateral sclerosis	0.00371	0.0125	CbGeAlD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00358	0.0102	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00351	0.00995	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00342	0.00971	CbGpPWpGaD
Etomidate—GABRA1—brain—amyotrophic lateral sclerosis	0.00328	0.011	CbGeAlD
Etomidate—CYP19A1—FSH signaling pathway—BDNF—amyotrophic lateral sclerosis	0.00325	0.00921	CbGpPWpGaD
Etomidate—GABRB2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00323	0.00916	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00302	0.00858	CbGpPWpGaD
Etomidate—CYP19A1—brain—amyotrophic lateral sclerosis	0.00301	0.0101	CbGeAlD
Etomidate—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00295	0.00837	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TPK1—amyotrophic lateral sclerosis	0.00275	0.00779	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0027	0.00767	CbGpPWpGaD
Etomidate—SLC2A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.00268	0.00761	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.00264	0.00748	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00262	0.00744	CbGpPWpGaD
Etomidate—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00258	0.00732	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CASP9—amyotrophic lateral sclerosis	0.00255	0.00723	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—MMP9—amyotrophic lateral sclerosis	0.00254	0.00721	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00247	0.00701	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00242	0.00687	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.0024	0.00681	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0024	0.0068	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00233	0.00661	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0023	0.00653	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0023	0.00653	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0023	0.00652	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00226	0.00641	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00221	0.00628	CbGpPWpGaD
Etomidate—SLC2A1—Disease—VTA1—amyotrophic lateral sclerosis	0.0022	0.00623	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00216	0.00613	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00214	0.00606	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00213	0.00604	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0021	0.00597	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0021	0.00595	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00204	0.00579	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00204	0.00579	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00198	0.00562	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00197	0.00559	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00196	0.00555	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00195	0.00555	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00193	0.00549	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00186	0.00528	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00184	0.00522	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00182	0.00516	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00182	0.00516	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0018	0.00511	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00176	0.00498	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—TP53—amyotrophic lateral sclerosis	0.00172	0.00489	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00171	0.00486	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00171	0.00485	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.00166	0.00472	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00166	0.00472	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00166	0.00472	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00161	0.00456	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00161	0.00456	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00158	0.00447	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00157	0.00445	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00155	0.00439	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00151	0.00428	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PLB1—amyotrophic lateral sclerosis	0.00151	0.00427	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00149	0.00424	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00149	0.00424	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00148	0.0042	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00147	0.00417	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00146	0.00413	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00146	0.00413	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00146	0.00413	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00145	0.00413	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0014	0.00398	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00139	0.00395	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00138	0.00392	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00137	0.00388	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00137	0.00388	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00135	0.00384	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00135	0.00382	CbGpPWpGaD
Etomidate—SLC2A1—Disease—VCP—amyotrophic lateral sclerosis	0.00134	0.00381	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00133	0.00379	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.00133	0.00378	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00133	0.00378	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00132	0.00374	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00128	0.00364	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00128	0.00362	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00127	0.00362	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00126	0.00358	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00123	0.00349	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00123	0.00349	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00122	0.00346	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00121	0.00343	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00121	0.00342	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0012	0.00341	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0012	0.00341	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.0012	0.00341	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00119	0.00339	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00119	0.00339	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00116	0.0033	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00114	0.00325	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00114	0.00325	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00113	0.00319	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00112	0.00319	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00112	0.00318	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00112	0.00318	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00111	0.00316	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0011	0.00312	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00108	0.00305	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.00107	0.00305	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00106	0.00302	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00105	0.00299	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00105	0.00297	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00105	0.00297	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00104	0.00294	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00104	0.00294	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00103	0.00291	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00102	0.0029	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.00102	0.00289	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00102	0.00289	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.001	0.00285	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000992	0.00281	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000984	0.00279	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000972	0.00276	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000967	0.00274	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CST3—amyotrophic lateral sclerosis	0.000963	0.00273	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000962	0.00273	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000955	0.00271	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000948	0.00269	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000933	0.00265	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000915	0.0026	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000915	0.0026	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000898	0.00255	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000882	0.0025	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00087	0.00247	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000829	0.00235	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000815	0.00231	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000798	0.00226	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000767	0.00218	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000756	0.00215	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000754	0.00214	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00075	0.00213	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000724	0.00205	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000723	0.00205	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CASP9—amyotrophic lateral sclerosis	0.0007	0.00199	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000687	0.00195	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000662	0.00188	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000659	0.00187	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000639	0.00181	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000619	0.00176	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000615	0.00175	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000615	0.00175	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000608	0.00173	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000608	0.00172	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000599	0.0017	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000588	0.00167	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000588	0.00167	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00058	0.00165	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000579	0.00164	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000568	0.00161	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000563	0.0016	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000563	0.0016	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000554	0.00157	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000548	0.00156	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000548	0.00155	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000537	0.00152	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000524	0.00149	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000521	0.00148	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000513	0.00146	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000502	0.00142	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0005	0.00142	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.0005	0.00142	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000492	0.0014	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000492	0.0014	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000477	0.00135	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000472	0.00134	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00047	0.00133	CbGpPWpGaD
Etomidate—SLC2A1—Disease—APOE—amyotrophic lateral sclerosis	0.000464	0.00132	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000456	0.00129	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000438	0.00124	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000438	0.00124	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000431	0.00122	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000425	0.00121	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000409	0.00116	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000393	0.00111	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000388	0.0011	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000377	0.00107	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000354	0.001	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000348	0.000988	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000347	0.000985	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000343	0.000974	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000322	0.000913	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00032	0.000907	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—amyotrophic lateral sclerosis	0.000318	0.000901	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000312	0.000886	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000312	0.000885	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000299	0.000849	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000297	0.000843	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000271	0.000768	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000269	0.000764	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000269	0.000762	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000268	0.000761	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000266	0.000755	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000265	0.000752	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000262	0.000744	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000247	0.0007	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000244	0.000692	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000243	0.00069	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000231	0.000657	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000231	0.000656	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000228	0.000648	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000223	0.000632	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000217	0.000615	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000213	0.000603	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00021	0.000595	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000203	0.000576	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000186	0.000529	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000184	0.000523	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000182	0.000518	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000175	0.000496	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000154	0.000437	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000153	0.000433	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00015	0.000425	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000139	0.000395	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000136	0.000386	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000131	0.000372	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000127	0.000359	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00012	0.000342	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.00012	0.00034	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000119	0.000338	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000119	0.000337	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000113	0.000321	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	9.91e-05	0.000281	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.68e-05	0.000275	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.1e-05	0.000258	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	9e-05	0.000255	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.04e-05	0.000228	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.48e-05	0.000212	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.79e-05	0.000193	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.18e-05	0.000175	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.76e-05	0.000135	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.5e-05	0.000128	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.04e-05	0.000115	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.05e-05	8.66e-05	CbGpPWpGaD
